Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

ClinicalTrials.gov ID: NCT04903626

Public ClinicalTrials.gov record NCT04903626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Single-Arm Prospective Study to Evaluate Safety and Efficacy of GLE/PIB 8-Week Treatment in Adults and Adolescents With Acute Hepatitis C Virus (HCV) Infection

Study identification

NCT ID
NCT04903626
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
286 participants

Conditions and interventions

Interventions

  • Glecaprevir/Pibrentasvir (GLE/PIB) Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 23, 2021
Primary completion
Sep 16, 2024
Completion
Sep 16, 2024
Last update posted
Apr 5, 2025

2021 – 2024

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
34
Facility City State ZIP Site status
Arizona Health Research /ID# 233558 Chandler Arizona 85225-2906
The Institute for Liver Health /ID# 228427 Peoria Arizona 85381
Liver Wellness Center /ID# 244933 Little Rock Arkansas 72204
AHF Research Center /ID# 254795 Beverly Hills California 90211
Velocity Clinical Research Chula Vista /ID# 238352 Chula Vista California 91911-6658
AHF Healthcare Center- Hollywood /ID# 254794 Los Angeles California 90027
TLC Clinical Research Inc /ID# 232334 Los Angeles California 90048
University of California, Davis Comprehensive Cancer Center /ID# 230814 Sacramento California 95817
Angels Clinical Research Institute /ID# 234090 Doral Florida 33122-1713
AIDS Healthcare Foundation (AHF) - Healthcare Center - Northpoint /ID# 254814 Fort Lauderdale Florida 33308
Midway Immunology and Research Center /ID# 229194 Ft. Pierce Florida 34982
Midland Research Group, Inc /ID# 231885 Oakland Park Florida 33334-4434
Orlando Immunology Center /ID# 229839 Orlando Florida 32803
Tampa General Hospital /ID# 228930 Tampa Florida 33606
Duplicate_Triple O Research Institute /ID# 229928 West Palm Beach Florida 33407-3100
Florida Medical Clinic /ID# 233489 Zephyrhills Florida 33542
Emory Midtown Infectious Disease Clinic /ID# 229927 Atlanta Georgia 30322
University of Iowa Hospitals and Clinics /ID# 226934 Iowa City Iowa 52242
Duplicate_University of Kentucky Chandler Medical Center /ID# 231588 Lexington Kentucky 40536
University of Louisville Hospital /ID# 232139 Louisville Kentucky 40202
Mercy Medical Center /ID# 226937 Baltimore Maryland 21202
Johns Hopkins Hospital /ID# 230694 Baltimore Maryland 21287
Henry Ford Hospital /ID# 226932 Detroit Michigan 48202
University of Mississippi Medical Center /ID# 232620 Jackson Mississippi 39216-4500
Las Vegas Research Center /ID# 255631 Las Vegas Nevada 89106
North Jersey Community Research Initiative (NJCRI) /ID# 245129 Newark New Jersey 07103-2842
Weill Cornell Medical College /ID# 230815 New York New York 10065
Coastal Research Institute, LLC /ID# 233233 Fayetteville North Carolina 28304
The Christ Hospital /ID# 231204 Cincinnati Ohio 45219
Duplicate_University Of Cincinnati Medical Center /ID# 226922 Cincinnati Ohio 45267-0585
Cherokee Nation Outpatient Health Center /ID# 232618 Tahlequah Oklahoma 74464-0545
Thomas Jefferson University Hospital /ID# 232624 Philadelphia Pennsylvania 19107
University Gastroenterology /ID# 233332 Providence Rhode Island 02905
Vanderbilt University Medical Center /ID# 241282 Nashville Tennessee 37232-0011
Liver Associates of Texas, P.A /ID# 229775 Houston Texas 77030-2783
Digestive and Liver Disease Sp /ID# 232633 Norfolk Virginia 23502
Wisconsin Medical Center /ID# 230116 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04903626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04903626 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →